Navigation Links
Swiss, EMA, US Pharmacopoeia and World Health Organization Authorities to Provide an Update on Cool Chain Regulations
Date:1/23/2012

LONDON, January 23, 2012 /PRNewswire/ --

Representatives of Swiss, EMA, US Pharmacopoeia and WHO will discuss the new regulatory landscape as well as provide the feedback from recent inspections of pharmaceutical manufacturers at 11th Annual Cool Chain Logistics Europe, 30 January - 01 February 2012 in Basel, Switzerland.

Over 400 attendees including senior representatives from : Novo Nordisk, Genzyme, Pfizer, Abbott, Pliva, Amgen, Bayer, GlaxoSmithKline, Johnson & Johnson, Ipsen, Roche, Novartis, Sanofi, Alcon Couvreur, Agilent, Allergan, Baxter, Bacher, Celgene, Biotest, Synthes, Shire Pharmaceuticals and Forest Laboratories will meet to discuss issues such as regulatory GDP guidelines, distribution partnerships and ambient transportation solutions.

For more information on the event, visit http://www.coolchaineurope.com/news, email: enquire@iqpc.co.uk or call: +44-(0)207-368 9300

Press are invited to attend this important industry forum. If you would like to a press pass, please email Joanna Checinska on joanna.checinska@iqpc.co.uk

Media contact:

Joanna Checinska
joanna.checinska@iqpc.co.uk
http://www.coolchaineurope.com

 



'/>"/>
SOURCE Pharma IQ
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Waters and NIBRT Complete Work on Worlds First UPLC Glycan Database
2. LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
3. The worlds smallest magnetic data storage unit
4. Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
5. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
6. U of Toronto experiment named top breakthrough of 2011 by Physics World
7. West Palm Beach, FL to Host 8th Annual World Stem Cell Summit December 3-5, 2012
8. StemCyte Adds World Class Talent to its North America and Global Operations
9. The worlds smallest steam engine
10. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
11. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
Breaking Biology Technology:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):